Marta Missiaggia

Marta Missiaggia

Auto-generated profile, based on publicly available information

Marta Missiaggia

Trento Institute for Fundamental Physics and Application (TIFPA) via Sommarive 15 38123 Trento Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Physical Review E
Verified
Journal Article
Closed access
PDF file
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
MMM. Missiaggia
M. Missiaggia
AAA. Attili
A. Attili
SWScott M Welford
Scott M Welford
ESE. Scifoni
E. Scifoni
CTC. La Tessa
C. La Tessa
The present work introduces a rigorous stochastic model, called the generalized stochastic microdosimetric model (GSM2), to describe biological damage induced by ionizing radiation. Starting from the microdosimetric spectra of energy deposition in tissue, we derive a master equation describing the time evolution of the probability density function of lethal and potentially lethal DNA damage induced by a given radiation to a cell nucleus. The resulting probability distribution is not required to satisfy any a priori conditions. After the initial assumption of instantaneous irradiation, we generalized the master equation to consider damage induced by a continuous dose delivery. In addition, spatial features and damage movement inside the nucleus have been taken into account. In doing so, we provide a general mathematical setting to fully describe the spatiotemporal damage formation and evolution in a cell nucleus. Finally, we provide numerical solutions of the master equation exploiting Monte Carlo simulations to validate the accuracy of GSM2. Development of GSM2 can lead to improved modeling of radiation damage to both tumor and normal tissues, and thereby impact treatment regimens for better tumor control and reduced normal tissue toxicities.

4 December 2020 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
MMM Missiaggia
M Missiaggia
GCG Cartechini
G Cartechini
Emanuele ScifoniEmanuele Scifoni
Emanuele Scifoni
MRM Rovituso
M Rovituso
FTFrancesco Tommasino
Francesco Tommasino
CTC La Tessa
C La Tessa
Relative biological effectiveness (RBE) variations are thought to be one of the primary causes of unexpected normal-tissue toxicities during tumor treatments with charged particles. Unlike carbon therapy, where treatment planning is optimized on the basis of the RBE-weighted dose, a constant RBE value of 1.1 is currently used in proton therapy. Assuming a uniform value can lead to under- or over-dosage, not just to the tumor but also to surrounding normal tissue. RBE changes have been linked with dose/fraction, the biological endpoint and beam properties. Understanding radiation quality and the associated RBE can improve the prediction of normal-tissue toxicities. In this study, we exploited microdosimetry for characterizing radiation quality in proton therapy in-field, and off-beam at 20 (beam edge), 50 (close out-of-field) and 100 (far out-of-field) mm from the beam center. We measured the lineal energy y spectra in a water phantom irradiated with 152 MeV protons, from which beam quality as well as the physical dose could be obtained. Taking advantage of the linear quadratic model and a modified version of the microdosimetric kinetic model, the microdosimetric data were combined with radiobiological parameters ( α and β ) of human salivary gland tumor cells for assessing cell survival RBE and RBE-weighted dose. The results indicate that if a dose of 60 Gy is delivered to the peak, the beam edge receives up to 6 Gy while the close and far out-of-field regions receive doses on the order of 10 −3 Gy and 10 −4 Gy, respectively. The RBE estimate in-beam shows large variations, ranging from 1.0 ± 0.2 at the entrance channel to 2.51 ± 0.15 at the tail. The beam edge follows a similar trend but the RBE calculated at the Bragg peak depth is 2.27 ± 0.17, i.e. twice the RBE in-beam (1.05 ± 0.15). Out-of-field, the estimated RBE is always significantly higher than 1.1 and increases with increasing lateral distance, reaching the overall highest value of 3.4 ± 0.3 at a depth of 206 mm and a lateral distance of 10 mm. The combination of RBE and dose into the biological dose points to the beam edge and the end-of-range in-beam as the areas with the highest risk of potential toxicities.

17 July 2024 in The European Physical Journal Plus
Verified
Journal Article
Open access
PDF file
MMMarta Missiaggia
Marta Missiaggia
Radiation-induced biological damage is primarily characterized by the average dose absorbed by the tissue. Nevertheless, it is acknowledged that other parameters, collectively constituting ”radiation quality,” play a crucial role in this context. However, defining and characterizing the radiation quality in radiotherapy to assess the radiobiological damage remains an open challenge. The most commonly used approach to quantify the radiation quality, the Linear Energy Transfer (LET), reveals many flaws in its applications. Microdosimetry represents an alternative approach that has been developed in the last decades and is considered a more accurate description of the radiation quality. Both approaches are explored, each with its inherent limitations and promising potential.

10 April 2023 in Physics in Medicine & Biology
Verified
Journal Article
Open access
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
MMMarta Missiaggia
Marta Missiaggia
Emanuele ScifoniEmanuele Scifoni
Emanuele Scifoni
CTChiara La Tessa
Chiara La Tessa
The present work develops ANAKIN: an Artificial iNtelligence bAsed model for (radiation-induced) cell KIlliNg prediction . ANAKIN is trained and tested over 513 cell survival experiments with different types of radiation contained in the publicly available PIDE database. We show how ANAKIN accurately predicts several relevant biological endpoints over a wide broad range on ion beams and for a high number of cell-lines. We compare the prediction of ANAKIN to the only two radiobiological models for Relative Biological Effectiveness prediction used in clinics, that is the Microdosimetric Kinetic Model and the Local Effect Model (LEM version III), showing how ANAKIN has higher accuracy over the all considered cell survival fractions. At last, via modern techniques of Explainable Artificial Intelligence (XAI), we show how ANAKIN predictions can be understood and explained, highlighting how ANAKIN is in fact able to reproduce relevant well-known biological patterns, such as the overkilling effect.

5 February 2024 in Physics in Medicine & Biology
Verified
Journal Article
Open access
GCGiorgio Cartechini
Giorgio Cartechini
MMMarta Missiaggia
Marta Missiaggia
Emanuele ScifoniEmanuele Scifoni
Emanuele Scifoni
CTChiara La Tessa
Chiara La Tessa
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
Objective. In this paper, we present MONAS (MicrOdosimetry-based modelliNg for relative biological effectiveness (RBE) ASsessment) toolkit. MONAS is a TOPAS Monte Carlo extension, that combines simulations of microdosimetric distributions with radiobiological microdosimetry-based models for predicting cell survival curves and dose-dependent RBE. Approach. MONAS expands TOPAS microdosimetric extension, by including novel specific energy scorers to calculate the single- and multi-event specific energy microdosimetric distributions at different micrometer scales. These spectra are used as physical input to three different formulations of the microdosimetric kinetic m odel , and to the generalized stochastic microdosimetric model (GSM 2 ), to predict dose-dependent cell survival fraction and RBE. MONAS predictions are then validated against experimental microdosimetric spectra and in vitro survival fraction data. To show the MONAS features, we present two different applications of the code: (i) the depth-RBE curve calculation from a passively scattered proton SOBP and monoenergetic 12 C-ion beam by using experimentally validated spectra as physical input, and (ii) the calculation of the 3D RBE distribution on a real head and neck patient geometry treated with protons. Main results. MONAS can estimate dose-dependent RBE and cell survival curves from experimentally validated microdosimetric spectra with four clinically relevant radiobiological models. From the radiobiological characterization of a proton SOBP and 12 C fields, we observe the well-known trend of increasing RBE values at the distal edge of the radiation field. The 3D RBE map calculated confirmed the trend observed in the analysis of the SOBP, with the highest RBE values found in the distal edge of the target. Significance. MONAS extension offers a comprehensive microdosimetry-based framework for assessing the biological effects of particle radiation in both research and clinical environments, pushing closer the experimental physics-based description to the biological damage assessment, contributing to bridging the gap between a microdosimetric description of the radiation field and its application in proton therapy treatment with variable RBE.

7 September 2022 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
MMMarta Missiaggia
Marta Missiaggia
EPEnrico Pierobon
Enrico Pierobon
CTChiara La Tessa
Chiara La Tessa
FCFrancesco Giuseppe Cordoni
Francesco Giuseppe Cordoni
In this work we present an advanced random forest-based machine learning (ML) model, trained and tested on Geant4 simulations. The developed ML model is designed to improve the performance of the hybrid detector for microdosimetry (HDM), a novel hybrid detector recently introduced to augment the microdosimetric information with the track length of particles traversing the microdosimeter. The present work leads to the following improvements of HDM: (i) the detection efficiency is increased up to 100%, filling not detected particles due to scattering within the tracker or non-active regions, (ii) the track reconstruction algorithm precision. Thanks to the ML models, we were able to reconstruct the microdosimetric spectra of both protons and carbon ions at therapeutic energies, predicting the real track length for every particle detected by the microdosimeter. The ML model results have been extensively studied, focusing on non-accurate predictions of the real track lengths. Such analysis has been used to identify HDM limitations and to understand possible future improvements of both the detector and the ML models.